AC
LLY icon

Allstate Corporation’s Eli Lilly LLY Stock Holding History

Allstate Corporation’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76M Buy
82,639
+21,441
+35% +$21.7M 0.81% 21
2025
Q4 		$65.8M Buy
61,198
+33,013
+117% +$31.6M 0.9% 20
2025
Q3 		$21.5M Buy
28,185
+26,589
+1,666% +$19.8M 0.49% 26
2025
Q2 		$1.24M Sell
1,596
-22,825
-93% -$17.7M 0.09% 41
2025
Q1 		$20.2M Buy
24,421
+429
+2% +$357K 0.59% 25
2024
Q4 		$18.5M Buy
23,992
+23,263
+3,191% +$19.3M 0.55% 23
2024
Q3 		$646K Sell
729
-1,960
-73% -$1.76M 0.06% 69
2024
Q2 		$2.43M Sell
2,689
-48
-2% -$38.4K 0.2% 50
2024
Q1 		$2.13M Sell
2,737
-15
-0.5% -$10.7K 0.15% 50
2023
Q4 		$1.6M Sell
2,752
-153
-5% -$89.3K 0.11% 58
2023
Q3 		$1.56M Hold
2,905
– – 0.09% 58
2023
Q2 		$1.36M Hold
2,905
– – 0.09% 61
2023
Q1 		$998K Sell
2,905
-34,149
-92% -$11.5M 0.07% 68
2022
Q4 		$13.6M Buy
37,054
+311
+0.8% +$110K 0.41% 35
2022
Q3 		$11.9M Hold
36,743
– – 0.34% 40
2022
Q2 		$11.9M Sell
36,743
-131
-0.4% -$39.3K 0.37% 39
2022
Q1 		$10.6M Sell
36,874
-18,630
-34% -$4.79M 0.28% 45
2021
Q4 		$15.3M Buy
55,504
+36,910
+199% +$9.36M 0.29% 53
2021
Q3 		$4.3M Sell
18,594
-1,809
-9% -$446K 0.18% 50
2021
Q2 		$4.68M Sell
20,403
-1,750
-8% -$352K 0.16% 51
2021
Q1 		$4.14M Buy
22,153
+1,523
+7% +$298K 0.13% 65
2020
Q4 		$3.48M Buy
20,630
+206
+1% +$30.8K 0.11% 68
2020
Q3 		$3.02M Sell
20,424
-4,329
-17% -$670K 0.1% 65
2020
Q2 		$4.06M Sell
24,753
-2,856
-10% -$438K 0.14% 57
2020
Q1 		$3.83M Sell
27,609
-64,032
-70% -$8.8M 0.15% 52
2019
Q4 		$12M Sell
91,641
-2
-0% -$232 0.22% 52
2019
Q3 		$10.2M Sell
91,643
-11,639
-11% -$1.3M 0.18% 57
2019
Q2 		$11.4M Sell
103,282
-15
-0% -$1.77K 0.2% 52
2019
Q1 		$13.4M Sell
103,297
-14
-0% -$1.7K 0.36% 41
2018
Q4 		$12M Buy
+103,311
New +$11.5M 0.39% 41
2017
Q3 		– Sell
-24,250
Closed -$2M – 158
2017
Q2 		$2M Buy
+24,250
New +$1.98M 0.11% 84
2016
Q1 		– Sell
-116,920
Closed -$9.85M – 156
2015
Q4 		$9.85M Buy
116,920
+74,274
+174% +$6.16M 0.94% 32
2015
Q3 		$3.57M Buy
42,646
+11,482
+37% +$969K 0.37% 65
2015
Q2 		$2.6M Sell
31,164
-39,238
-56% -$2.99M 0.23% 93
2015
Q1 		$5.12M Buy
70,402
+9,224
+15% +$657K 0.43% 62
2014
Q4 		$4.22M Sell
61,178
-62,577
-51% -$4.22M 0.32% 108
2014
Q3 		$8.03M Sell
123,755
-96,926
-44% -$6.14M 0.37% 62
2014
Q2 		$13.7M Buy
220,681
+65,129
+42% +$3.89M 0.37% 81
2014
Q1 		$9.16M Buy
155,552
+60,184
+63% +$3.36M 0.29% 96
2013
Q4 		$4.86M Hold
95,368
– – 0.18% 140
2013
Q3 		$4.8M Hold
95,368
– – 0.19% 126
2013
Q2 		$4.68M Buy
+95,368
New +$5.19M 0.21% 117

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Allstate Corporation's LLY Position: Q1 2026 in Review

Allstate Corporation increased its Eli Lilly (LLY) stake by 35% in Q1 2026, buying an estimated $21.7M and bringing the position to 82,639 shares worth $76M. The position accounts for 0.81% of the portfolio, ranked #21.

Allstate Corporation first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allstate Corporation held 82,639 shares of Eli Lilly worth $76M as of Q1 2026.
  • Allstate Corporation bought 21,441 Eli Lilly shares in Q1 2026, an estimated $21.7M.
  • Eli Lilly made up 0.81% of Allstate Corporation's portfolio in Q1 2026, its #21 holding.
  • Allstate Corporation first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.